SEP 9, 2026 · PHASE 1/2 TRIAL
Safety and Preliminary Effectiveness of BNT317, an Investigational Therapy for Advanced Solid Tumors
ClinicalTrials.gov
First-in-human Phase 1/2 study registration with no posted results; safety and dose-escalation design in early development stage.
Reported
Estimated enrollment248
Study phasePhase 1/Phase 2
Primary outcome (Part A)Occurrence of dose-limiting toxicities (DLT…